Abiopharma

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

Lillys orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

BioNTech schließt Übernahme von CureVac N.V. samt damit verbundener Nachangebotsfrist ab und stärkt so die einzigartige Position im mRNA-Feld

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

PureTech Appoints Robert Lyne as Chief Executive Officer

Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference

Incyte gibt Zulassung von Minjuvi® (Tafasitamab) durch die Europäische Kommission zur Behandlung von rezidiviertem oder refraktärem follikulärem Lymphom bekannt

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

InMed Announces Results of 2025 Annual General and Special Meeting